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Tile effects of ZnCi 2 on [3H]GABA binding to GABA A and GABA B binding sites were investigated using receptor autoradiography. At 
concentrations exceeding 100 g.M, zinc non-competitively inhibited GABA n binding in a dose dependent fashion. GABAAbinding was not 
inhibited significantly by zinc eliminating the possibility of a non-specific effect of zinc. Increased calcium concentrations up to 10 mM enhanced 
total GABA n binding but did not prevent zinc induced inhibition of GABA n binding, indicating a separate site of action for these cations at the 
GABAB binding site. In some regions, zinc modulates GABA a binding in a biphasic manner as concentrations of 10-100 g.M zinc significantly 
enhanced GABA n binding in the hippocampus and the molecular layer of the cerebellum but not in the thalamus. These results provide further 
evidence for a neuromodulatory role for zinc in the central nervous system. 
INTRODUCTION 
Zinc is widely distributed throughout the mammali- 
an central nervous system and may function as a neu- 
romodulator. Zinc-containing neuronal pathways t°, 
zinc-containing synaptic vesicles is, calcium-dependent 
zinc release TM, and zinc uptake mechanisms 23 have 
been identified. Zinc modulates the function of various 
neurotransmitters. Zinc non-competitively inhibits 
NMDA receptors t7,~9,24 by either non-competitive an- 
tagonism of glycine binding 26 or direct antagonism of 
NMDA receptors 9. Zinc interacts biphasically with 
non-NMDA excitatory amino acid receptors, exciting 
them at low zinc concentrations and inhibiting them at 
higher concentrations D. NMDA receptor-mediated 
glutamate neurotoxicity is also inhibited by zinc s,~3 
while zinc enhances non-NMDA receptor-mediated 
glutamate neurotoxicity t3. Zinc also inhibits GABA A 
receptor-mediated inhibitory responses in cultured 
n e u r o n s  4'15'16'2l'22'24. Binding studies have revealed in- 
hibition of [3H]GABA binding to synaptic membranes 
by zinc 2. While much of the research concerning zinc 
and GABA transmission has focused on the GABA A 
receptor, there is also some evidence for zinc modula- 
tion of GABA a receptor activity. Xie and Smart have 
proposed that zinc induces giant depolarizing poten- 
tials (GDPs) in hippocampal neurons by inhibition of 
pre- and postsynaptic GABA n recep tors2s. Drew et al. 
have shown that 100 /zM zinc inhibits [3H]baclofen 
binding to cerebellar membranes 7 but there has been 
no further characterization of zinc effects on GABA n 
binding. We now report dose-dependent modulation of 
GABA n binding by zinc in several brain regions. 
MATERIALS AND METHODS 
Quantitative autoradiography was used to analyze the effect of 
varying concentrations of ZnCI 2 on [3H]GABA binding to GABA A 
and GABA n binding sites, to assess the effect of [Ca 2 +] on zinc- 
GABA n receptor interactions, and to determine the nature of the 
interaction between zinc and GABA n binding by performing satura- 
tion analysis of GABA n binding in the presence and absence of zinc. 
Male Sprague-Dawley rats (175-225 g; Harlan Industries, Indi- 
anapolis) were decapitated and brains were rapidly dissected and 
frozen in Lipshaw embedding matrix surrounded by powdered dry 
ice. Twenty-~m sections were cut in the horizontal plane on a 
Lipshaw cryostat at -20°C and thaw mounted onto gelatin-coated 
slides. Sections were stored at -20°C for no longer than 24 h. 
Sections were run in triplicate. Sections underwent a 30-rain pre-wash 
in buffer containing 50 mM Tris-HCI and 2.5 mM CaC! 2 (pH 7.4 at 
+40C) and were then dried under a stream of cool air. GABA n 
binding sites were examined with [3H]GABA (Amersham, Arlington 
Heights, IL) in the presence of 10 /zM isoguvacine (Cambridge 
Research Chemicals, Cambridge, UK) and non-specific binding was 
determined in the presence of 100/zM baclofen (gift of Ciba-Geigy, 
Basel, Switzerland) while GABA A binding sites were examined with 
[3H]GABA in the presence of 100 ~M baclofen and nan-specific 
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binding was determined in the presence of 10 ~M isoguvacine*. 
Assay conditions included a 45-min incubation at + 4°(2 in 50 mM 
Tris-HCI and 2.5 mM CaCI 2. Following incubation, slides were 
removed individually an~ rinsed 3 times with 3 ml buffer and once 
with 3 ml 2.5% gluteraldehyde in acetone and immediately blown dry 
with warm air. Slides were mounted in an X-ray cassette and 
opposed to tritium sensitive film (3H-Hyperfilm, Amersham) along 
with [ 1~*C] plastic standards containing known amounts of radioactiv- 
ity (ARC, Inc., St. Louis, MO) for 3 weeks (competition analysis) or 6 
weeks (saturation analysis) at + 4°C. Films were developed in Kodak 
D-19, fixed and dried. The optical densities of the images were 
determined with computer-assisted densitometry using an MCID 
system (Imaging Research; St. Catherine's, Ont.). Ten to twenty-five 
readings were taken with a variable size cursor in each region 
examined and averaged together. Bound radioactivity was calculated 
from film optical densities with a standard curve obtained by fitting 
the optical density of the standards against their radioactivity with a 
fourth degree polynomial equation. 
Zinc modulation of [3H]GABA binding to GABA A and GABA B 
binding sites was analyzed in 3 separate experiments. Two experi- 
ments included concentrations of ZnCI 2 from 1/~M to 3 mM in the 
incubation mixture with 20 nM [3H]GABA (91.7 Ci/mmol; n = 3 
animals) and the third included concentrations of ZnCI 2 from 1 nM 
to 1 mM with 20 nM [3H]GABA (61 Ci/mmol; n = 3 animals). The 
effect of calcium concentration on the modulation of GABA a bind- 
ing by 500/~M zinc was analyzed at 5 concentrations of CaCI 2 from 
1.0 mM to 10.0 mM ([3H]GABA =91 Ci/mmol; n - -3  animals). 
Saturation studies were performed using the method of isotopic 
dilution of 10 nM [3H]GABA (91.7 Ci/mmol) with non-radioactive 
GABA (Sigma; n = 3 animals). The range of total GABA concentra- 
tions was 10-650 nM. GABA n binding and non-specific binding 
were determined at all concentrations of GABA in both the pres- 
ence and the absence of 400/zM ZnCI2. 3 
For analysis of zinc modulation of [- H]GABA binding, specific 
bindin~ was assessed in the neocortex, dentate gyrus and CAI 
regions of the hippocampus, striatum, thalamus, and granule cell 
layer and molecular layer of the cerebellum. IC50 values for each 
ligand were calculated from standard dose-response semi-log plots. 
For analysis of the effect of calcium concentration on zinc modula- 
tion of GABA n binding, specific binding was assessed in the molecu- 
lar layer of the cerebellum. In the saturation experiments, values of 
specific [311]GABA bound were quantified in the neocortex, thala- 
mus and the molecular layer of the cerebellum to construct Scatchard 
plots. 
Fig. 1. Zinc inhibits GABA B binding with little effect on GABA A 
binding. Autoradiographs of [3H]GABA binding to GABA n binding 
sites in the absence (A) and presence (B) of 1 mM zinc and to 
GABA A binding sites in the absence (C) and presence (D) of 1 mM 
zinc. Side to side variations in binding are due to a rinse effect and 
are accounted for in the data analysis by measuring and averaging 
data from both sides of the sections. 
RESULTS 
Zinc displayed a dose-dependent biphasic effect on 
[3H]GABA binding to the GABA B binding site. At 
concentrations higher than 100 /~M, zinc inhibited 
GABAa binding in all areas examined with ICs0 values 
approximating 500 ~M (Table I). GABAA binding was 
inhibited slightly by zinc but 50% inhibition was not 
reached by the highest concentration of zinc in the 
assay (3 raM), indicating that the effect on GABA a 
TABLE I 
Inhibition of [ ~H]GABA binding to GABA B binding sites in various brain regions by zinc 
IC5o values were derived from inhibition curves with ZnCI 2 (see text). K D (nM) and Bma x (fmol/mg protein) values were determined in the 
presence and absence of 400 ~M ZnCi 2 (see text). 
Brain Region ICso (I~M) Ko( - Zn) KD( + Zn) B,,,ax( - Zn) B,,,~x( + Zn) 
Cerebellum 
Molecular layer 505 98.5 113.0 1969.3 1353.3 * 
Granule cell layer 400 
Striatum 710 
Thalamus 515 119.6 120.6 1585.8 1222.7 
Hippocampus 
Dentate 1020 
CAl 1 105 
Neocortex 620 127.9 114.8 1 189.0 807.1 * 
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Fig. 2. Modulation of ['~H]GABA binding to OABA A (ra) and GABA a (o) binding sites by increasing concentrations of zinc in the granule cell 
layer (GABA A) and the molecular layer (GABA a) of the cerebellum (A), in CAI (B) and in thalamus (C). At concentrations between 10 and 100 
/zM, zinc enhances GABA n binding in cerebellum and hippocampus, while no enhancement is seen in thalamus. Saturation analysis of 
['~H]GABA binding to GABA a binding sites in the molecular layer of the cerebellum in the presence ( - ) and absence (o)  of 400/zM zinc (D). 
binding is not a non-specific effect (Figs. 1 and 2). 
Increased calcium concentration up to 10 mM CaCI 2 
did not prevent inhibition of GABA a binding by 500 
pM zinc (Fig. 3). At zinc concentrations of 10-100 
/.t M, GABA a binding was enhanced in some areas. In 
comparison to GABA a binding in the absence of zinc, 
l0 pM zinc enhanced GABA n binding by 15% in the 
molecular layer of the cerebellum (P < 0.05, two-tailed 
t-test; Fig. 2A), 30/zM zinc enhanced GABA n binding 
by 27% in the dentate gyrus (P < 0.005, two-tailed 
t-test) and 82% in CAI of the hippocampus (P < 0.005, 
two-tailed t-test), and 100/zM zinc enhanced GABA a 
binding by 33% in the dentate gyrus (P < 0.005, two- 
tailed t-test) and 56% in CAl of the hippocampus 
(P < 0.05, two-tailed t-test; Fig. 2B). However, GABA a 
binding in the thalamus was not increased by 10-100 
~M zinc (Fig. 2C). 
Saturation analysis revealed a non-competitive inhi- 
bition of GABA B binding by 400/~M zinc (Fig. 2D). 
K D values for [3H]GABA binding in the presence and 
in the absence of zinc did not differ significantly in 
either the cerebellar molecular layer or in the neocor- 
tex while the Bma x in the presence of zinc was signifi- 
cantly lower (Table I). The difference in the Bma x 
values in the thalamus approached significance at the 
0.05 level (Table I) and the plot resembled that of a 
non-competitive inhibition of [3H]GABA binding to 
the GABA a binding site by zinc. 
DISCUSSION 
Our results provide further evidence for a neuro- 
modulatory role for zinc in the central nervous system. 
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Fig. 2. Modulation of ['~H]GABA binding to GABA A (~)  ~md GABA n (e) binding sites by increasing concentrations of zinc in the granule cell 
layer (GABA A) and the molecular layer (GABA [J) of the cerebellum (A), in CAI (B) and in thalamus (C). At concentrations between 10 and 100 
~.M, zinc enhances GABAI~ binding in cerebellum and hippocampus, while no enhancement is seen in th~damus. Saturation analysis of 
[3H]GABA binding to GABA t~ binding sites in the molecular layer of the cerebellum in the presence ( A ) and absence (o) of 400 ~M zinc (D). 
binding is not a non-specific effect (Figs. 1 and 2). 
Increased calcium concentration up to 10 mM CaCI 2 
did not prevent inhibition of GABAa binding by 500 
~M zinc (Fig. 3). At zinc concentrations of 10-100 
M, GABA B binding was enhanced in some areas. In 
comparison to GABA B binding in the absence of zinc, 
10/~M zinc enhanced GABA n binding by 15% in the 
molecular layer of the cerebellum (P < 0.05, two-tailed 
t-test; Fig. 2A), 30 ;zM zinc enhanced GABA n binding 
by 27% in the dentate gyrus (P < 0.005, two-tailed 
t-test) and 82% in CAI of the hippocampus (P < 0.005, 
two-tailed t-test), and 100 ~M zinc enhanced GABA B 
binding by 33% in the dentate gyrus (P < 0.005, two- 
tailed t-test) and 56% in CAI of the hippocampus 
(P < 0.05, two-tailed t-test; Fig. 2B). However, GABA B 
binding in the thalamus was not increased by 10-100 
/zM zinc (Fig. 2C). 
Saturation analysis revealed a non-competitive inhi- 
bition of GABA a binding by 400 ~M zinc (Fig. 2D). 
K o values for [3H]GABA binding in the presence and 
in the absence of zinc did not differ significantly in 
either the cerebellar molecular layer or in the neocor- 
tex while the Bma x in the presence of zinc was signifi- 
cantly lower (Table I). The difference in the Bin,, x 
values in the thalamus approached significance at the 
0.05 level (Table I) and the plot resembled that of a 
non-competitive inhibition of [3H]GABA binding to 
the GABA a binding site by zinc. 
DISCUSSION 
Our results provide further evidence for a neuro- 
modulatory role for zinc in the central nervous system. 
Our findings are consistent with the physiological data 
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of zinc are not mediated by the same site responsible 
for Ca 2+ stimts!ation of GABA a binding. Our results 
are consistent g~th a hypothesis that zinc at low con- 
centrations might' enhance GABAn binding by acting 
at one site where calcium also acts, while at higher 
concentrations zinc would inhibit GABAs binding by 
acting at a second site. Interestingly, zinc also affects 
the electrophysiological responses of non-NMDA re- 
ceptors in a biphasic manner, potentiating these re- 
sponses at 50 ~M  zinc and inhibiting the responses at 
1 mM zinc ~. 
The regional heterogeneity of zinc effects on 
GABA n binding also suggests GABA B receptor het- 
erogeneity within the central nervous system. Evidence 
is accumulating in support of GABA a receptor hetero- 
geneity 3'2°. We have shown that zinc modulates 
GABA n binding biphasically in some regions but only 
inhibits GABA ~ binding in others, suggesting regional 
differences in GABA B receptors. 
REFERENCES 
1 Assaf, S.Y. and Chung, S.-H., Release of endogenous Zn 2+ from 
brain tissue during activity, Nature, 308 (1984) 734-736. 
2 Baraldi, M., Caselgrandi, E. and Sand, M., Effect of zinc on 
specific binding of GABA to rat brain membranes, in C.J. Fred- 
erickson, G.A. Howell and E.J. Kasarskis (Eds.), The Neurobiol- 
ogy of Zinc, Part A: Physiochemistry, Anatomy, and Techniques, 
Alan R. Liss, New York, 1984, pp. 59-71. 
3 Bowery, N.G., Knott, C., Moratalla, R. and Pratt, G.D., GABA n 
receptors and their heterogeneity, in G. Biggio and E. Costa 
(Eos.), GABA and Benzodiazep#,,e Receptr)r 3ubtypes, Raven, New 
York, 1990, pp. 127-139. 
4 Celentano, JJ., Gyenes, M., Gibbs. T.T. and Farb, D.H., Nega- 
tive modulation of the y-aminob~t~,r:c acid response by extracel. 
lular zinc, Mol. Pharmacol., 40 (1~)~1) 760--773. 
5 Charton, G., Rovira, C., Ben-Ari, Y. ~nd Leviel, V., Spontaneous 
and evoked release of endo~,~tv.~us Zn 2+ in the hippocampal 
mossy fiber zone of the rat in ~u ,  Exp. 8rain Res., 58 (1985) 
202-205, 
6 Chu, D.C.M., AIbin, R.L., Young, A,fi a ~  Penny, .I.B., Distribu- 
tion and kinetics of GABA n binding .~i~es m rat central nervous 
system: a quantitative autoradi~.;~)a~bic study, Neuroscience, 34 
(1990), 341-357. 
7 Drew, C.A., Johnston, G.A.R. and Wea~.herby, R.P., Bicuculline- 
insensitive GABA receptors: Studies on the binding of ( - ) -  
baclofen to rat cerebellar membranes, NeuroscL Lett., 52 (1984) 
317-321. 
8 Eimerl, S. and Schramm, M., Acute glutamate toxicity in cultured 
cerebellar granule cells: agonist potency, effects of pH, Zn 2÷ and 
the potentiation by serum albumin, Brain Res., 560 (1991) 282- 
290. 
9 Forsythe, i.D., Westbrook, G.L. and Mayer, M.L., Modulation of 
excitatory synaptic transmission by glycine and zinc in cultures of 
mouse hippocampal neurons, J. Neurosci., 8 (1988) 3733-3741. 
10 Frederickson, CJ., Neurobiolo~ of zinc and zinc-containing neu- 
rons, lnt. Rer. Neurobiol., 31 (1989) 145-238. 
11 Howell, G.A., Welch, M.G. and Frederickson, C.3., Stimulation- 
induced uptake and release of zinc in hippocampal slices, Nature, 
308 (1984) 736-738. 
12 Kato, K., Goto, M. and Fukuda, H., Regulation by divalent 
cations of 3H-baclofen binding to GABA sites in rat cerebeUar 
membranes, Life Sci., 32 (1983) 879-887. 
13 Koh, .l. and Choi, D.W., Zinc alters excitatory amino acid neuro- 
toxicity on cortical neurons, J. Neurosci., 8 (1988)2164-2171. 
14 Lambert, N.A., Levitin, M. and Harrison, N.L., Induction of giant 
depolarizing potentials by zinc in area CAI of the rat hippocam- 
pus does not result from block of GABA B receptors, Neurosci. 
Left., 135 (1992) 215-218. 
15 Legendre, P. and Westbrook, G.L., Noncompetitive inhibition of 
y-aminobutyric acid A channels by Zn, Mol. Pharmacol., 39 (1991) 
267-274. 
16 Mayer, M.L. and Vyklicky, L., The action of zinc on synaptic 
transmission and neuronal excitability in cultures of mouse hip- 
pocampus, I. Physiol., 415 (1989) 351-365. 
17 Mayer, M.L., Vyklicky, L. and Westbrook, G.L., Modulation of 
excitatory amino acid receptors by group lIB metal cations in 
cultured mouse hippocampal neurones, ./. Physiol., 415 (1989) 
329-350. 
18 Perez-Clausell, P. and Danscher, G., Intravesicular localization of 
zinc in rat telencephalic boutons. A histochemical study, Brain 
Res., 337 (1985) 91-98. 
19 Peters, S., Koh, J. and Choi, D.W., Zinc selectively blocks the 
action of N-methyI-D-aspartate on cortical neurons, Science, 236 
(1987) 589-593. 
20 Scherer, R.W., Ferkany, J.W. and Enna, S.J., Evidence for phar- 
macologically distinct subsets of GABA B receptors, Brain Res. 
BuR, 21 (1988)439-443. 
21 Smart, T,O., A novel modulatory binding site for zinc on the 
GABA A receptor complex in cultured rat neurons, J. Physiol., 
447 (1992) 587-625. 
22 Smart, T.G. and Constanti, A., Differential effect of zinc on the 
vertebrate OABAA.receptor complex, Br. J. Phannacol., 99 (1990) 
643 -654. 
23 Wensink, J., Molenaar, AJ., Woroniecka, U,D. and Van den 
Hamer, CJ.A., Zinc uptake into synaptosomes, J. Neurochem., 50 
(1988) 782-789. 
24 Westbrook, G.L. and Mayer, M.L., Micromolar concentrations of 
Zn 2+ antagonize NMDA and GABA responses of hippocampal 
neurons, Nature, 328 (1987) 640-643. 
25 Xie, X. and Smart, T.G., A physiological role for endogenous 
zinc in rat hippocampal synaptic neurotransmission, Nature, 349 
(1991) 521-524. 
26 Yeh, G.-C., Bonhaus, D.W. and McNamara, J.O., Evidence that 
zinc inhibits N-methyl-o-aspartate receptor-gated ion channel 
activation by noncompetitive antagonism of glycine binding, Mol. 
Pharmacol., 38 (1990) 14-19. 
